OGEN
Price
$0.19
Change
-$0.02 (-9.52%)
Updated
Apr 4, 10:30 AM (EDT)
Capitalization
4.44M
SRPT
Price
$56.91
Change
-$1.70 (-2.90%)
Updated
Apr 4, 11:11 AM (EDT)
Capitalization
5.69B
26 days until earnings call
Ad is loading...

OGEN vs SRPT

Header iconOGEN vs SRPT Comparison
Open Charts OGEN vs SRPTBanner chart's image
Oragenics
Price$0.19
Change-$0.02 (-9.52%)
Volume$3.5K
Capitalization4.44M
Sarepta Therapeutics
Price$56.91
Change-$1.70 (-2.90%)
Volume$3.08K
Capitalization5.69B
OGEN vs SRPT Comparison Chart
Loading...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OGEN vs. SRPT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGEN is a Hold and SRPT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (OGEN: $0.21 vs. SRPT: $58.61)
Brand notoriety: OGEN: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OGEN: 26% vs. SRPT: 235%
Market capitalization -- OGEN: $4.44M vs. SRPT: $5.69B
OGEN [@Biotechnology] is valued at $4.44M. SRPT’s [@Biotechnology] market capitalization is $5.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGEN’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • OGEN’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, both OGEN and SRPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGEN’s TA Score shows that 4 TA indicator(s) are bullish while SRPT’s TA Score has 4 bullish TA indicator(s).

  • OGEN’s TA Score: 4 bullish, 4 bearish.
  • SRPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both OGEN and SRPT are a good buy in the short-term.

Price Growth

OGEN (@Biotechnology) experienced а -11.62% price change this week, while SRPT (@Biotechnology) price change was -18.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.06%. For the same industry, the average monthly price growth was -13.16%, and the average quarterly price growth was -15.02%.

Reported Earning Dates

OGEN is expected to report earnings on May 15, 2023.

SRPT is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-7.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($5.69B) has a higher market cap than OGEN($4.44M). OGEN YTD gains are higher at: -44.002 vs. SRPT (-51.797). SRPT has higher annual earnings (EBITDA): 317M vs. OGEN (-19.94M). SRPT has more cash in the bank: 1.36B vs. OGEN (3.14M). OGEN has less debt than SRPT: OGEN (519K) vs SRPT (1.34B). SRPT has higher revenues than OGEN: SRPT (1.9B) vs OGEN (0).
OGENSRPTOGEN / SRPT
Capitalization4.44M5.69B0%
EBITDA-19.94M317M-6%
Gain YTD-44.002-51.79785%
P/E RatioN/A25.05-
Revenue01.9B-
Total Cash3.14M1.36B0%
Total Debt519K1.34B0%
FUNDAMENTALS RATINGS
OGEN vs SRPT: Fundamental Ratings
OGEN
SRPT
OUTLOOK RATING
1..100
7857
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10046
PRICE GROWTH RATING
1..100
9595
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGEN's Valuation (49) in the Biotechnology industry is in the same range as SRPT (70). This means that OGEN’s stock grew similarly to SRPT’s over the last 12 months.

OGEN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that OGEN’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for OGEN (100). This means that SRPT’s stock grew somewhat faster than OGEN’s over the last 12 months.

SRPT's Price Growth Rating (95) in the Biotechnology industry is in the same range as OGEN (95). This means that SRPT’s stock grew similarly to OGEN’s over the last 12 months.

SRPT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as OGEN (100). This means that SRPT’s stock grew similarly to OGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OGENSRPT
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
62%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 15 days ago
82%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
66%
View a ticker or compare two or three
Ad is loading...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VPV10.300.03
+0.29%
Invesco Pennsylvania Value Municipal Income Trust
YDEC23.45-0.31
-1.32%
FT Vest Intl Eq Mod Bffr ETF Dec
KROP9.75-0.31
-3.13%
Global X AgTech & Food Innovation ETF
KOLD19.49-0.97
-4.74%
ProShares UltraShort Bloomberg Natrl Gas
RSPT32.08-2.61
-7.52%
Invesco S&P 500® Equal Weight Tech ETF